Donna Nichol

Company: Natera

Job title: Senior Director, Market Development, Europe

Seminars:

Adapting Clinical Development to an MRD-Integrated Treatment Landscape 9:50 am

Signatera™ MRD testing is transforming cancer care across tumour types in the US, with growing global adoption in clinical trials. Its impact on patient management is an increasingly important consideration for clinical development strategy Analyses from Phase 3 studies demonstrated that MRD-based patient selection can reveal treatment benefits not observed in unselected populations. Incorporating MRD…Read more

day: Day 2 AM